A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis

Yonsei Medical Journal

Volumn 46, Issue 4, 2005, Pages 496-502

  Yoon, Hee Jung ^a   Choi, Jun Yong ^a   Kim, Chang Oh ^a   Kim, June Myung ^a   Song, Young Goo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Bacteremia; Endocarditis; Staphylococcus aureus

Indexed keywords

CEPHALOSPORIN DERIVATIVE; HABEKACIN; METICILLIN; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; RELIABILITY; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 24644465980     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.4.496     Document Type: Article

References (61)

1. Nissen H, Nielsen PF, Frederiksen M, Helleberg C, Nielsen JS. Native valve infective endocarditis in the general population: a 10-year survey of the clinical picture during the 1980s. Eur Heart J 1992;13:872-7.
2. Netzer ROM, Zollinger E, Seiler C, Cerny A. Infective endocarditis: Clinical spectrum, presentation and outcome: an analysis of 212 cases 1980-1995. Heart 2000;84: 23-30.
3. Sanabria TJ, Alpert JS, Goldberg R, Pape LA, Cheeseman SH. Increasing frequency of staphylococcal infective: endocarditis: experience at a university hospital. Arch Intern Med 1990;150:1305-9.
4. Manford M, Matharu J, Farrington K. Infective endocarditis in a district general hospital. J R Soc Med 1992 85:262-6.
5. Skehan JD, Murray M, Mills PG. Infective endocarditis: incidence and mortality in the north east Thames region. Br Heart J 1988;59:62-8.
6. Cho BC, Lee JH, Park JW, Hong CS, Kim JM, Kang SM, et al. Subacute bacterial endocarditis associated with upper endoscopy. Yonsei Med J 2004;45:936-40.
7. Chong Y, Lim HS, Lee SY, Cho SY. Lactobacillus casei subspecies casei endocarditis - a case report. Yonsei Med J 1991;32:69-73.
8. Chong Y, Yoon KJ, Lee SY, Chung NS. Erysipelothrix rhusiopathiae endocarditis - a case report. Yonsei Med J 1986;27:239-43.
9. Chong Y, Kim TS, Lee SY, Shim WH, Choo BK. Cardiobacterium hominis endocarditis - a case report. Yonsei Med J 1985;26:78-81.
10. Chong Y, Lee KW, Lee SY, Cho SY. Isolation of Actinobacillus actinomycetemcomitans from the blood of a patient with subacute bacterial endocarditis. Yonsei Med J 1983;24:54-8.
11. Chong Y, Song KS, Lee SY. Neisseria subflava infections-bacteriological aspects of two cases. Yonsei Med J 1975;16:44-9.
12. Chung Y, Lee SY. Vibrio fetus human infection-isolation from a subacute bacterial endocar-ditis case. Yonsei Med J 1970;11:126-30.
13. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.
14. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987;9:891-907.
15. Soriano A, Martinez JA, Mensa J, Marco F, Almela M, Moreno-Martinez A, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000;30:368-73.
16. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996,23:255-9.
17. Darouiche RO, Musher DM. Editorial response: increasing rates of Staphylococcus aureus bacteremia - a medical device is a merit in disguise and methicillin resistance is merely a vice. Clin Infect Dis 1996;23:260-1.
18. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995;21:1417-23.
19. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
20. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: 12th international supplement. NCCLS document M100-S12:22:1. Wayne PA: NCCLS; 2002.
21. Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. J Intern Med 1997;242:15-22.
22. Espersen F, Frimodt-Moller N. Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med 1986;146:1118-21.
23. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users: prognostic features in 102 episodes. Ann Intern Med 1992;117:560-6.
24. Manolis AS, Melita H. Echocardiographic and clinical correlates in drug addicts with infective endocarditis. Implications in vegetation size. Arch Intern Med 1988; 148:2461-5.
25. Watanakunakorn C. Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases. Arch Intern Med 1994;154:2330-5.
26. Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine 1993;72:90-102.
27. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-4.
28. Nakatani S, Mitsutake K, Hozumi T, Yoshikawa J, Akiyama M, Yoshida K, et al. Current characteristics of infective endocarditis in Japan: an analysis of 848 cases in 2000 and 2001. Circ J 2003;67:901-5.
29. Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 2003;82:322-32.
30. Chang FY. Staphylococcus aureus bacteremia and endocarditis. J Microbiol Immunol Infect 2000;33:63-8.
31. Peacock JE, Moorman D, Wenzel RP, Mandell GL. Methicillin-resistant Staphylococcus aureus: microbiological virulence of an epidemiologic strain. J Infect Dis 1981;144:575-82.
32. Cutler RR. Relationship between antibiotic resistance, the production of "virulence factors" and virulence for experimental animals in Staphylococcus aureus. J Med Microbial 1979;12:55-62.
33. French GL, Cheng AF, Ling JM, Mo P, Donnan S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990;15:117-25.
34. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994;150:1545-9.
35. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 2001;32:877-83.
36. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002;162:2229-35.
37. Talon D, Woronoff-Lemsi MC, Limat S, Bertrand X, Chatillon M, Gil H, et al. The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality. Eur J Intern Med 2002;13:31-6.
38. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998;19:32-7.
39. Ibelings MM, Bruining HA. Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 1998; 164:411-8.
40. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-8.
41. Cheng AF, French GL. Methicillin-resistant Staphylococcus aureus bacteremia in Hong Kong. J Hosp Infect 1988;12:91-101.
42. Topeli A, Unal S, Akalin HE. Risk factors influencing clinical outcome in Staphylococcus aureus bacteremia in a Tukish University Hospital. Int J Antimicrob Agents 2000;14:57-63.
43. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-9.
44. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998;158:182-9.
45. Tumbarello M, De Gaetano Donati K, Tacconelli E, Citton R, Spanu T, Leone F, et al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002;50:375-82.
46. Roghmann MC. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000;160:1001-4.
47. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000;31:1170-4.
48. Lewis E, Saravolatz LD. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control 1985;13:109-14.
49. Hershow RC, Khayr WF, Smith NL. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol 1992;13:587-93.
50. Mylotte JM, Aeschlimann JR, Rotella DL. Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect Control Hosp Epidemiol 1996;17:165-8.
51. Marty L, Flahault A, Suarez B, Caillon J, Hill C, Andremont A. Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteremic cancer patients. Intensive Care Med 1993;19:285-9.
52. Selvey LA, Whitby M, Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol 2000;21:645-8.
53. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprimsulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992;117:390-8.
54. Mizushima Y, Kawasaki A, Hirata H, Daimon Y, Oosaki R, Morinaga S, et al. An analysis of bacteremia in a university hospital in Japan over a 10-year period. J Hosp Infect 1994;28:285-98.
55. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994; 13:96-102.
56. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes, JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-40.
57. Lesens O, Hansmann Y, Brannigan E, Remy V, Hopkins S, Martinot M, et al. Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteremia. J Infect 2004;48:245-52.
58. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991;115:674-80.
59. Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989;2:1071-3.
60. Chang FY, Turnidge J. Staphylococcus aureus. In: Yu VL, Merigan TC, Barriere S, editors. Antimicrobial chemotherapy and vaccines. 1st ed. Baltimore: Williams & Wilkins; 1999. p.389-404.
61. Mortara LA, Bayer AS. Staphylococcus aureus bacteremia and endocarditis. Infect Dis Clin North Am 1993;7:53:-68.